SEP 22, 2026 · JOURNAL ARTICLE
Incidence, Risk Factors, and Renal Outcomes of Cancer Patients Treated With Immune Checkpoint Inhibitor: A Retrospective Cohort Study in a Single Tertiary Hospital in the Philippines
Philippine Journal of Internal Medicine
Introduction: Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that target inhibitory receptors expressed on T cells and are associated with a variety of immune-relate